HIGHLIGHTS
- who: Megumi Nishikubo from the Clinical trial registration This study was registered with the University Hospital Medical Information Network (UMIN) in have published the article: Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur-uracil as postoperative adjuvant chemotherapy, in the Journal: (JOURNAL) of July/16,/2021
- what: This study evaluates the immunogenic status and safety of SARS-CoV-2 vaccines for patients with non-small-cell lung cancer (NSCLC) receiving tegafur-uracil (UFT) as postoperative adjuvant chemotherapy. This study demonstrated that patients can receive COVID-19 vaccines without discontinuation of UFT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.